Found: 19
Select item for more details and to access through your institution.
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 795, doi. 10.1634/theoncologist.2015-0480
- By:
- Publication type:
- Article
A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 851, doi. 10.1634/theoncologist.2015-0361
- By:
- Publication type:
- Article
Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 825, doi. 10.1634/theoncologist.2015-0447
- By:
- Publication type:
- Article
Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 832, doi. 10.1634/theoncologist.2015-0416
- By:
- Publication type:
- Article
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 848, doi. 10.1634/theoncologist.2015-0522
- By:
- Publication type:
- Article
Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 869, doi. 10.1634/theoncologist.2015-0354
- By:
- Publication type:
- Article
Those Who Pay Have a Say: A View on Oncology Drug Pricing and Reimbursement.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 779, doi. 10.1634/theoncologist.2016-0119
- By:
- Publication type:
- Article
Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 855, doi. 10.1634/theoncologist.2015-0248
- By:
- Publication type:
- Article
Treatment Summaries and Follow-Up Care Instructions for Cancer Survivors: Improving Survivor Self-Efficacy and Health Care Utilization.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 817, doi. 10.1634/theoncologist.2015-0517
- By:
- Publication type:
- Article
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 785, doi. 10.1634/theoncologist.2016-0060
- By:
- Publication type:
- Article
Efficacy and Safety of Everolimus in Extra pancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 875, doi. 10.1634/theoncologist.2015-0420
- By:
- Publication type:
- Article
Getting Past No in Cancer Care.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 782, doi. 10.1634/theoncologist.2016-0187
- By:
- Publication type:
- Article
Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors?
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 887, doi. 10.1634/theoncologist.2015-0468
- By:
- Publication type:
- Article
Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic Leukemia.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 840, doi. 10.1634/theoncologist.2015-0391
- By:
- Publication type:
- Article
Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 895, doi. 10.1634/theoncologist.2016-0006
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 804, doi. 10.1634/theoncologist.2015-0509
- By:
- Publication type:
- Article
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 787, doi. 10.1634/theoncologist.2016-0145
- By:
- Publication type:
- Article
A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 789, doi. 10.1634/theoncologist.2016-0011
- By:
- Publication type:
- Article
Inside Out.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 868, doi. 10.1634/theoncologist.2016-0002
- By:
- Publication type:
- Article